New data presented at the 2025 ASH demonstrates 94% disease free and overall survival rate Omisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic Anemia Key Highlights of Data ...
Oxford’s 2025 Word of the Year, 'rage bait' isn't just a social trend. Longevity expert Dr Mark Hyman reveals the biological ...
Zymedi (CEO Sunghoon Kim) announced that the World Health Organization (WHO) has assigned rapaprutug as the International Nonproprietary Name (INN) for the company's first-in-class antibody therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback